CD19 and mantle cell lymphoma: They reported eight patients that were infused with CD-19 – targeting CAR-T cells [2 with adult ALL, 2 CLL, 1 mantle cell lymphoma (MCL), 2 DLBCL, 1 transformed follicular lymphoma (FL)], and the clinical responses were seen in 6 of them (2 of them had CAR-T infusion just before the publication).